44 filings
8-K
NVNO
enVVeno Medical Corporation
24 Apr 24
Regulation FD Disclosure
6:15am
8-K
NVNO
enVVeno Medical Corporation
6 Mar 24
Regulation FD Disclosure
8:40am
8-K
NVNO
enVVeno Medical Corporation
7 Dec 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
NVNO
enVVeno Medical Corporation
16 Nov 23
Regulation FD Disclosure
8:45am
8-K
NVNO
enVVeno Medical Corporation
12 Oct 23
Entry into a Material Definitive Agreement
5:00pm
8-K
8916g2una7doe rues9
6 Dec 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K/A
uvf19g1urq23
3 Dec 21
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
t8llyp00csfzq2i69kqo
1 Dec 21
Submission of Matters to a Vote of Security Holders
9:30am
8-K
b5lnv7r4alergptgzqey
1 Oct 21
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
55tv8nf0k
22 Sep 21
Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs
8:15am
8-K
8rv2tevkuzc41 ipe52
8 Sep 21
Entry into a Material Definitive Agreement
4:49pm
8-K
4xb67g bziugn
12 Aug 21
Entry into a Material Definitive Agreement
5:28pm
8-K
03vn8nyi41yb4
24 Feb 21
Departure of Directors or Certain Officers
5:15pm
8-K
zn5cjzj foxlc4o6gi83
12 Feb 21
Hancock Jaffe Laboratories Announces Pricing of Upsized
5:05pm
8-K
a3huxewcq3xr1n s9d
21 Dec 20
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
st67ok
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
5kbdsqvk kkwv0ub
24 Nov 20
Unregistered Sales of Equity Securities
5:15pm
8-K
guye9
8 Oct 20
Entry into a Material Definitive Agreement
5:25pm
8-K
r7ouxcbcgw
16 Sep 20
Amendments to Articles of Incorporation or Bylaws
5:27pm
8-K
l15 g56455hn1o
21 Jul 20
Hancock Jaffe Laboratories Announces Pricing of $5.6 Million Offering
5:24pm